FDA has awarded up to $6 million in grants to support the development of pediatric medical devices. The awards are in the form of five grants that will be distributed over the next five years to the following organizations nationwide: Philadelphia Pediatric Medical Device Consortium, National Capital Consortium for Pediatric Device Innovation 2.0, Southwest National Pediatric Device Consortium, University of California San Francisco-Stanford Pediatric Device Consortium, and West Coast Consortium for Technology and Innovation in Pediatrics.
“We know that developing products specifically for pediatric patients can present unique challenges to device developers and there are still many unmet needs for children with serious, debilitating or rare diseases. This is why we continue to work to encourage device innovation for medical conditions that impact young populations. Our Pediatric Device Consortia Grant Program is one of a number of initiatives underway to foster the development and approval of safe and effective pediatric-specific medical devices.” – Scott Gottlieb, M.D., FDA
The consortia will provide expertise to device developers in a range of areas, including intellectual property, engineering, prototyping, lab testing and clinical trial design.
The program has awarded $37 million to consortia since 2009. According to the FDA, 19 pediatric devices have been made available will the help of the grants.
Related Articles
-
The MDDT program was developed in collaboration with the National Institutes of Health’s (NIH’s) National Institute of Drug Abuse (NIDA), National Institute of Dental Craniofacial Research (NIDCR) and National Cancer Institute (NCI) as a way for the FDA to qualify…
-
“Addressing unmet needs across pediatric populations is critical to advancing children’s health, and we are delighted to once again work with pioneering companies that seek to bridge this care gap."
-
As 3D printing gains a more prominent place in the manufacture and protoyping of medical devices, advances in technology and materials are expanding indications. We spoke with John Kawola, CEO of Boston Micro Fabrication (BMF), about the move toward micro…
-
The FDA is asking stakeholders to submit public comments on how it should use any portion of the user fee funding that may be distributed to external organizations—other than NEST—to support premarket RWE in medical device evaluation and development.
